Ukusebenzisa Cannabinoids Ukwelapha Refractory Epilepsy, Dementia kanye Alzheimer's

A BAMBA Ukukhululwa Kwamahhala | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

I-MGC Pharmaceuticals Ltd. isayine isivumelwano esikhethekile sokusabalalisa ne-Sciensus Rare, ingxenye yeqembu lokunakekelwa kwezempilo lase-UK, i-Sciensus, ukuze kusatshalaliswe i-CannEpil® ne-CogniCann® ezindaweni ezibalulekile zaseYurophu nase-UK.        

Isivumelwano esokusatshalaliswa ezindaweni ezibalulekile zaseYurophu nase-UK ngeCannEpil®, esetshenziselwa ukwelapha Isithuthwane Esingazweli Ezidakamizwa, kanye ne-CogniCann®, esetshenziselwa ukwelapha iziguli ezine-Dementia kanye nesifo i-Alzheimer's.

I-Sciensus Rare yinkampani yamazwe ngamazwe eyenza imithi ezinze eNetherlands, esebenza ngokukhethekile ekuhlinzekweni kwemithi yezifo ezingavamile ngokusebenzisa izivivinyo zomtholampilo ezihlukaniselwe abantu kanye nezinhlelo zokufinyelela ngokushesha kwezokwelapha, enolwazi olungaphezu kweminyaka engama-30 ekuhlinzekeni ngezinsizakalo zokunakekelwa kwezempilo, nokwandisa ukufinyelela kwezokwelashwa emikhiqizweni. INtshonalanga Yurophu.

Ngaphansi kwemibandela yesivumelwano sokusabalalisa, i-Sciensus Rare iqokwe njengomsabalalisi okhethekile we-CannEpil® ne-CogniCann® e-Denmark, e-France, e-Italy, e-Spain, e-Luxembourg nase-United Kingdom, ezinye zezimakethe zemithi ezithuthuke kakhulu emhlabeni, ukuze isikhathi sokuqala seminyaka emi-4. Ngemuva kwezinyanga eziyi-12 zokuqala zesivumelwano, i-Sciensus Rare izoba ngaphansi kwezimfuneko ze-oda lokuthenga ukuze igcine isimo sayo esikhethekile somsabalalisi. Amaqembu avumile ukuthi i-MGC Pharma izoqhubeka nokuba nesibopho sokufuna Ukugunyazwa Kwemakethe kulezi zindawo, kuyilapho i-Sciensus Rare izobhekana nezicelo Ezinhlelweni Zokufinyelela Ngaphambili Nezinhlelo Zeziguli Eziqanjwe Kaziwe.

U-Roby Zomer, uMqondisi Ophethe kanye ne-CEO ye-MGC Pharma, uphawule wathi: “I-Sciensus Rare iyinkampani esebenza kahle kakhulu yezemithi, enolwazi nolwazi oludingekayo ukuze kwandiswe ukufinyelela emtholampilo kuzo zombili i-CannEpil® ne-CogniCann® kulezo ziguli ezidinga kakhulu.

Lesi esinye isinyathelo esibalulekile ekwandiseni ukufinyelela kwesiguli emikhiqizweni yethu yemithi, futhi sibeka uhlelo lwesikhathi eside lokwakha inethiwekhi yokusabalalisa edingekayo eNtshonalanga Yurophu, okungenye yezimakethe zemithi ezibaluleke kakhulu emhlabeni.”

UGareth Williams, uMongameli we-Sciensus Rare, uphawule wathi: “Sijabule kakhulu ukusebenza ngokubambisana ne-MGC Pharmaceuticals emakethe yomhlaba wonke ethokozisayo ye-cannabis yezokwelapha futhi sibheke ngabomvu ukusekela odokotela ukuze bakwazi ukufinyelela kokubili i-CannEpil® ne-CogniCann®.”

LOKHO ONGAKUTHATHE KULESI SIHLOKO:

  • Under the terms of the distribution agreement, Sciensus Rare has been appointed the exclusive distributor of CannEpil® and CogniCann® in Denmark, France, Italy, Spain, Luxembourg, and the United Kingdom, some of the most advanced pharmaceutical markets in the world, for an initial 4-year term.
  • I-Sciensus Rare yinkampani yamazwe ngamazwe eyenza imithi ezinze eNetherlands, esebenza ngokukhethekile ekuhlinzekweni kwemithi yezifo ezingavamile ngokusebenzisa izivivinyo zomtholampilo ezihlukaniselwe abantu kanye nezinhlelo zokufinyelela ngokushesha kwezokwelapha, enolwazi olungaphezu kweminyaka engama-30 ekuhlinzekeni ngezinsizakalo zokunakekelwa kwezempilo, nokwandisa ukufinyelela kwezokwelashwa emikhiqizweni. INtshonalanga Yurophu.
  • This is another important step in widening patient access to our pharmaceutical products, and puts in place a long term plan to build the distribution networks required in Western Europe, one of the most important pharmaceutical markets in the world.

<

Mayelana umbhali

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...